AdAlta Limited (1AD.AX)
AUD 0.01
(-16.67%)
AUD 0.01
(-16.67%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 1.73 Million AUD | -49.91% |
| 2023 | 3.46 Million AUD | 25.99% |
| 2022 | 2.75 Million AUD | -30.89% |
| 2021 | 3.98 Million AUD | 4.09% |
| 2020 | 3.82 Million AUD | 8.17% |
| 2019 | 3.53 Million AUD | 75.17% |
| 2018 | 2.02 Million AUD | 12.43% |
| 2017 | 1.79 Million AUD | 143.45% |
| 2016 | 738.04 Thousand AUD | -16.88% |
| 2015 | 887.92 Thousand AUD | 19.23% |
| 2014 | 744.73 Thousand AUD | -8.39% |
| 2013 | 812.91 Thousand AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | - AUD | -100.0% |
| 2024 Q4 | 597.93 Thousand AUD | 0.0% |
| 2024 Q2 | 1.13 Million AUD | 0.0% |
| 2023 Q4 | 2.35 Million AUD | 0.0% |
| 2023 FY | 3.46 Million AUD | 25.99% |
| 2023 Q2 | 1.1 Million AUD | 0.0% |
| 2022 Q4 | 2.02 Million AUD | 0.0% |
| 2022 Q2 | 727.26 Thousand AUD | 0.0% |
| 2022 FY | 2.75 Million AUD | -30.89% |
| 2021 Q4 | 224.35 Thousand AUD | 0.0% |
| 2021 Q2 | 806.5 Thousand AUD | 0.0% |
| 2021 FY | 3.98 Million AUD | 4.09% |
| 2020 Q2 | 386.51 Thousand AUD | 0.0% |
| 2020 Q4 | 229.3 Thousand AUD | 0.0% |
| 2020 FY | 3.82 Million AUD | 8.17% |
| 2019 FY | 3.53 Million AUD | 75.17% |
| 2019 Q2 | 34.87 Thousand AUD | 0.0% |
| 2019 Q4 | 3.5 Million AUD | 0.0% |
| 2018 Q4 | 1.98 Million AUD | 0.0% |
| 2018 Q2 | 37.92 Thousand AUD | 0.0% |
| 2018 FY | 2.02 Million AUD | 12.43% |
| 2017 Q2 | 32.46 Thousand AUD | 0.0% |
| 2017 FY | 1.79 Million AUD | 143.45% |
| 2017 Q4 | 1.76 Million AUD | 0.0% |
| 2016 Q1 | 2404.00 AUD | 0.0% |
| 2016 Q4 | 733.23 Thousand AUD | 0.0% |
| 2016 Q2 | 4807.00 AUD | 99.96% |
| 2016 FY | 738.04 Thousand AUD | -16.88% |
| 2015 FY | 887.92 Thousand AUD | 19.23% |
| 2014 FY | 744.73 Thousand AUD | -8.39% |
| 2013 FY | 812.91 Thousand AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acrux Limited | 5.09 Million AUD | 65.865% |
| Amplia Therapeutics Limited | 4.45 Million AUD | 60.972% |
| Biome Australia Limited | 13 Million AUD | 86.641% |
| BTC Health Limited | 16.36 Thousand AUD | -10522.237% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 76.698% |
| CSL Limited | 22.41 Billion AUD | 99.992% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 84.897% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 98.029% |
| Noxopharm Limited | 2.4 Million AUD | 27.6% |
| PharmAust Limited | - AUD | -Infinity% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -94.789% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 53.189% |
| PYC Therapeutics Limited | 22.05 Million AUD | 92.122% |
| Race Oncology Limited | 4 Million AUD | 56.593% |
| Starpharma Holdings Limited | 8.28 Million AUD | 79.035% |
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 97.385% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -188.757% |
| Memphasys Limited | 60 Thousand AUD | -2796.33% |
| Nyrada Inc. | - AUD | -Infinity% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 99.65% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | -9385.797% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | -1730.186% |
| Patrys Limited | 1.39 Million AUD | -24.648% |
| Dimerix Limited | 583.47 Thousand AUD | -197.834% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 99.251% |
| Orthocell Limited | 5.31 Million AUD | 67.306% |
| Imugene Limited | - AUD | -Infinity% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 24.954% |
| Immutep Limited | 3.5 Million AUD | 50.43% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -10122.341% |
| Alterity Therapeutics Limited | 4.01 Million AUD | 56.764% |
| Nanollose Limited | 12.5 Thousand AUD | -13801.272% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -43.352% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | -38.849% |
| Biotron Limited | - AUD | -Infinity% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -480.76% |
| Tissue Repair Ltd | 152.24 Thousand AUD | -1041.486% |
| AnteoTech Limited | 460.39 Thousand AUD | -277.456% |
| Hexima Limited | - AUD | -Infinity% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -2541.03% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | -266.972% |
| Actinogen Medical Limited | 9.93 Million AUD | 82.502% |
| Immuron Limited | 4.9 Million AUD | 64.555% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 33.109% |